Search
IDEXX Laboratories Inc
IDXXAdd to Watchlist
570.210USD
+9.830+1.75%
Close 10-26 16:00（ET）
44.92BMarket Cap
41.67P/E TTM
IDEXX Laboratories Inc (IDXX) Stock Price Target & Forecast
Analyst Rating
Based on 16 analysts giving stock ratings to IDEXX Laboratories Inc in the past month.
Buy
5 Strong Buy
5 Buy
6 Hold
0 Sell
0 Strong Sell
Target Price
712.958USD+27.23%
IDXX Analyst Recommendation Trends
In the current month, IDXX has received 5 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. IDXX average Analyst price target in the last month is 712.958.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
5
5
5
5
5
5
5
5
5
4
4
4
4
5
6
6
6
6
7
7
7
7
5
5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16
15
16
16
16
17
16
16
IDXX Analyst Rating for Peer Comparison
Updated: Oct 20, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Medtronic PLC
MDT
9
11
11
0
0
31
Dexcom Inc
DXCM
13
13
4
0
0
30
Stryker Corp
SYK
10
14
5
0
0
29
Abbott Laboratories
ABT
11
14
4
0
0
29
Medline Ord Shs Class A
MDLN
10
12
6
0
0
28
Zimmer Biomet Holdings Inc
ZBH
2
6
20
0
0
28
Guardant Health Inc
GH
12
13
2
0
0
27
Insulet Corp
PODD
7
7
12
0
0
26
Tandem Diabetes Care Inc
TNDM
5
8
11
0
0
24
Repligen Corp
RGEN
5
13
3
0
0
21
Financial Forecasting
Based on analysts' estimates, IDXX EPS is projected to reach 3.741 in FY2026Q3, following reported EPS of 4.286 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
2.93
3.40
3.94
3.74
3.40
Actual
3.11
3.50
4.29
--
--
Surprise
+6.08%
+2.86%
+8.74%
--
--
FAQs
What is IDEXX Laboratories Inc's expected revenue for the next quarter?
IDEXX Laboratories Inc's expected revenue is 1.19B.
What is IDEXX Laboratories Inc's price target?
Analysts forecast that IDEXX Laboratories Inc's price target is USD 706.03, with the highest forecast at USD 805.00 and the lowest forecast at USD 472.45.
How have IDEXX Laboratories IncIDXX's recent earnings per share performed?
The market expectation was USD 4.29, while IDEXX Laboratories IncIDXX's earnings per share (EPS) for the previous quarter was USD 3.50. EPS for the next quarter is expected at USD 3.74.
What is the analyst rating for IDEXX Laboratories Inc?
Based on the ratings of IDEXX Laboratories Inc's stock from 16 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.